197 related articles for article (PubMed ID: 26944000)
1. Stress impairs the efficacy of immune stimulation by CpG-C: Potential neuroendocrine mediating mechanisms and significance to tumor metastasis and the perioperative period.
Levi B; Matzner P; Goldfarb Y; Sorski L; Shaashua L; Melamed R; Rosenne E; Page GG; Ben-Eliyahu S
Brain Behav Immun; 2016 Aug; 56():209-220. PubMed ID: 26944000
[TBL] [Abstract][Full Text] [Related]
2. Deleterious synergistic effects of distress and surgery on cancer metastasis: Abolishment through an integrated perioperative immune-stimulating stress-inflammatory-reducing intervention.
Matzner P; Sorski L; Haldar R; Shaashua L; Benbenishty A; Lavon H; Azan Y; Sandbank E; Melamed R; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2019 Aug; 80():170-178. PubMed ID: 30851377
[TBL] [Abstract][Full Text] [Related]
3. CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination.
Goldfarb Y; Benish M; Rosenne E; Melamed R; Levi B; Glasner A; Ben-Eliyahu S
J Immunother; 2009 Apr; 32(3):280-91. PubMed ID: 19242372
[TBL] [Abstract][Full Text] [Related]
4. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
Sorski L; Melamed R; Matzner P; Lavon H; Shaashua L; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2016 Nov; 58():91-98. PubMed ID: 27235931
[TBL] [Abstract][Full Text] [Related]
5. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
6. Prevention of liver metastases through perioperative acute CpG-C immune stimulation.
Sorski L; Melamed R; Levi B; Matzner P; Lavon H; Rosenne E; Shaashua L; Ricon I; Sandbank E; Benbenishty A; Ben-Eliyahu S
Cancer Immunol Immunother; 2020 Oct; 69(10):2021-2031. PubMed ID: 32405793
[TBL] [Abstract][Full Text] [Related]
7. Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression.
Avraham R; Benish M; Inbar S; Bartal I; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2010 Aug; 24(6):952-8. PubMed ID: 20362661
[TBL] [Abstract][Full Text] [Related]
8. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.
Rosenne E; Shakhar G; Melamed R; Schwartz Y; Erdreich-Epstein A; Ben-Eliyahu S
Brain Behav Immun; 2007 May; 21(4):395-408. PubMed ID: 17240115
[TBL] [Abstract][Full Text] [Related]
9. Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.
Naor R; Domankevich V; Shemer S; Sominsky L; Rosenne E; Levi B; Ben-Eliyahu S
Brain Behav Immun; 2009 Jul; 23(5):611-21. PubMed ID: 18951972
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity and resistance to tumor metastasis in prepubescent rats: deficient baselines, but invulnerability to stress and beta-adrenergic stimulation.
Page GG; Ben-Eliyahu S
Neuroimmunomodulation; 2000; 7(3):160-8. PubMed ID: 10754404
[TBL] [Abstract][Full Text] [Related]
11. In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.
Rosenne E; Sorski L; Shaashua L; Neeman E; Matzner P; Levi B; Ben-Eliyahu S
Brain Behav Immun; 2014 Mar; 37():207-19. PubMed ID: 24333572
[TBL] [Abstract][Full Text] [Related]
12. Continuous stress disrupts immunostimulatory effects of IL-12.
Levi B; Benish M; Goldfarb Y; Sorski L; Melamed R; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2011 May; 25(4):727-35. PubMed ID: 21277367
[TBL] [Abstract][Full Text] [Related]
13. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.
Benish M; Bartal I; Goldfarb Y; Levi B; Avraham R; Raz A; Ben-Eliyahu S
Ann Surg Oncol; 2008 Jul; 15(7):2042-52. PubMed ID: 18398660
[TBL] [Abstract][Full Text] [Related]
14. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
Shakhar G; Ben-Eliyahu S
J Immunol; 1998 Apr; 160(7):3251-8. PubMed ID: 9531281
[TBL] [Abstract][Full Text] [Related]
15. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Glasner A; Avraham R; Rosenne E; Benish M; Zmora O; Shemer S; Meiboom H; Ben-Eliyahu S
J Immunol; 2010 Mar; 184(5):2449-57. PubMed ID: 20124103
[TBL] [Abstract][Full Text] [Related]
16. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures.
Melamed R; Bar-Yosef S; Shakhar G; Shakhar K; Ben-Eliyahu S
Anesth Analg; 2003 Nov; 97(5):1331-1339. PubMed ID: 14570648
[TBL] [Abstract][Full Text] [Related]
17. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors.
Ben-Eliyahu S; Shakhar G; Page GG; Stefanski V; Shakhar K
Neuroimmunomodulation; 2000; 8(3):154-64. PubMed ID: 11124582
[TBL] [Abstract][Full Text] [Related]
18. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Goldfarb Y; Sorski L; Benish M; Levi B; Melamed R; Ben-Eliyahu S
Ann Surg; 2011 Apr; 253(4):798-810. PubMed ID: 21475023
[TBL] [Abstract][Full Text] [Related]
19. Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.
Matzner P; Sorski L; Shaashua L; Elbaz E; Lavon H; Melamed R; Rosenne E; Gotlieb N; Benbenishty A; Reed SG; Ben-Eliyahu S
Int J Cancer; 2016 Apr; 138(7):1754-64. PubMed ID: 26453448
[TBL] [Abstract][Full Text] [Related]
20. Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.
Ben-Eliyahu S; Shakhar G; Shakhar K; Melamed R
Br J Cancer; 2000 Dec; 83(12):1747-54. PubMed ID: 11104576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
